Snap Diagnostics Study
Payments companies reported to CMS as associated with Snap Diagnostics Study. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Snap Diagnostics Study, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Snap Diagnostics Study
These are the largest totals companies reported as associated with Snap Diagnostics Study. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Lisa Shives | San Diego, CA | Sleep Medicine (Internal Medicine) | $605,808.00 |
| Roukan Jazayerli | Orland Park, IL | $309,250.00 | |
| Muhammad Najjar | Northbrook, IL | Sleep Medicine (Psychiatry & Neurology) | $242,290.67 |
| Dianne Augelli | New York, NY | Internal Medicine | $151,500.00 |
| Simmy Pinto | Melbourne, FL | Pulmonary Disease | $125,000.00 |
| Jonathan Lindman | Evans, GA | $52,750.00 | |
| Tittymol Mathew | Toms River, NJ | Internal Medicine | $20.52 |
| Bhavik Khatri | Fresno, CA | Cardiovascular Disease | $17.14 |
| Hussam Kujok | Carmichael, CA | Internal Medicine | $16.61 |
| John Jameson | Pinehurst, NC | Family Medicine | $16.20 |
Prescribed Snap Diagnostics Study?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.